Mold-Tek Packaging Q2 FY27 PAT Surges 36% to ₹21.09 Cr on 30.7% Revenue Growth
Mold-Tek Packaging's Q2 FY27 Net Profit rose 36.06% to ₹21.09 crore, with revenue up 30.73% to ₹274.23 crore. EBITDA increased 29.80% to ₹51.27 crore, and sales volume grew 10.08%. Pharma and FMCG packaging segments showed strong growth. New product launches are planned from Q3FY27.
The announcement details strong financial performance with substantial growth percentages in key metrics like net profit and revenue, indicating a significant positive impact on the company's valuation and investor sentiment.
The company reported significant year-on-year growth in net profit, revenue, and EBITDA, along with positive volume growth across key segments. The management commentary also reflects confidence in future performance and strategic initiatives.
Mold-Tek Packaging Limited announced strong financial results for the quarter and half-year ended September 30, 2026. The company reported a significant 36.06% year-on-year increase in Net Profit, reaching ₹21.09 crore for the second quarter of FY2027. Revenue from operations saw a robust growth of 30.73%, amounting to ₹274.23 crore.
EBITDA for the quarter grew by 29.80% to ₹51.27 crore, and sales volume increased by 10.08% to 11,028.46 metric tons. This performance was driven by strong volume growth in the Pharma Packaging segment (26.30%) and Food & FMCG Packaging (23.70%), which more than offset a decline in Lubricants Packaging.
For the half-year ended September 30, 2027, Mold-Tek Packaging reported a 27.62% increase in revenue to ₹574.67 crore and a 23.18% rise in Net Profit to ₹46.67 crore. EBITDA for the half-year increased by 23.97% to ₹107.70 crore.
Chairman & Managing Director, Mr J Lakshmana Rao, highlighted the company's ability to protect operating margins by passing on increased raw material costs and improving operational efficiencies. He also noted the growing demand for its product range and the strategic focus on expanding the Pharma Packaging business.
Future prospects include the commercial production of IODEX containers from Q3FY27, new pack development for multinational companies expected to add revenues from Q4FY27, and the launch of innovative dual packs in Q4. The company is also exploring new segments like Trays, Dosing Pens, and Semi-conductors packaging.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.